Dr Klaus Ley, from the La Jolla Institute for Immunology, talks about his research on inflammation in atherosclerosis, as well as a potential vaccine against atherosclerosis.
Lucia Novak, director of Riverside Diabetes Center, discusses the benefits of long-acting insulins and barriers that may prevent more widespread implementation of these therapies.
Dr David Nash, founding dean of the Jefferson College of Population Health, discusses the patient- and physician-level impact of rising pharmaceutical prices, and outlines steps he says are needed to truly...
Dr Emily Johnson from Johns Hopkins University School of Medicine talks about her research on late-onset epilepsy, the midlife risk factors that may contribute to late-onset epilepsy, and more.
Lucia Novak, director of Riverside Diabetes Center in Maryland, defines clinical inertia and outlines patient- and practitioner-level factors that may impede appropriate management of your patients’...
Dr Shelley Cole, from Texas Biomedical Research Institute, answers our questions about her ongoing study, "The Strong Heart Study in American Indians," and how those results impact practice.
Ruchi S. Gupta, MD, MPH, from the Northwestern University Feinberg School of Medicine, and Christopher Warren, PhD(c), from the Keck School of Medicine of USC, discuss their research and the role of primary...
In this 3-minute mini-podcast, Dr James Matera from CentraState Medical Center discusses how the 2017 ACC/AHA hypertension guideline has changed the landscape when it comes to managing comorbid...
In the final installment of this podcast series, Robert S. Laitman, MD, from Bronx Westchester Medical Group and SARDAA discusses suicidality in patients with schizophrenia compared with the general...
He talks to us about the controversy around asthma-COPD overlap, the diagnostic challenges associated with overlap, and how to treat patients who do not fall into one box or the other.
